+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tendinitis Treatment Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • January 2022
  • Region: Global
  • TechNavio
  • ID: 5531080
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the tendinitis treatment market and it is poised to grow by $ 5.27 bn during 2022-2026, progressing at a CAGR of 6.79% during the forecast period. Our report on the tendinitis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising geriatric population and the increasing prevalence of sports injuries. In addition, rising geriatric population is anticipated to boost the growth of the market as well.

The tendinitis treatment market analysis includes the type segment and geographic landscape.

The publisher's tendinitis treatment market is segmented as below:


By Type


  • Non-surgical treatment
  • Surgical treatment

By Geographical Landscape


  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing awareness of tendonitis treatment options as one of the prime reasons driving the tendinitis treatment market growth during the next few years.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on tendinitis treatment market covers the following areas:
  • Tendinitis treatment market sizing
  • Tendinitis treatment market forecast
  • Tendinitis treatment market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tendinitis treatment market vendors that include Abbott Laboratories, Alvogen ehf, AstraZeneca Plc, Bayer AG, GlaxoSmithKline Plc, HydroCision Inc., Merck and Co. Inc., MiMedx Group Inc., RAG-Stiftung, and Seikagaku Corp. Also, the tendinitis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2021
  • Market outlook: Forecast for 2021 - 2026

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Type
  • Market segments
  • Comparison by Type
  • Non-surgical treatment - Market size and forecast 2021-2026
  • Surgical treatment - Market size and forecast 2021-2026
  • Market opportunity by Type

Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2021-2026
  • Europe - Market size and forecast 2021-2026
  • Asia - Market size and forecast 2021-2026
  • ROW - Market size and forecast 2021-2026
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Vendor landscape
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Alvogen ehf
  • AstraZeneca Plc
  • Bayer AG
  • GlaxoSmithKline Plc
  • HydroCision Inc.
  • Merck and Co. Inc.
  • MiMedx Group Inc.
  • RAG-Stiftung
  • Seikagaku Corp.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2021 - 2026 ($ million)
13: Global market: Year-over-year growth 2021 - 2026 (%)
14: Five forces analysis 2021 & 2026
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2021
21: Type - Market share 2021-2026 (%)
22: Comparison by Type
23: Non-surgical treatment - Market size and forecast 2021-2026 ($ million)
24: Non-surgical treatment - Year-over-year growth 2021-2026 (%)
25: Surgical treatment - Market size and forecast 2021-2026 ($ million)
26: Surgical treatment - Year-over-year growth 2021-2026 (%)
27: Market opportunity by Type
28: Customer landscape
29: Market share By Geographical Landscape 2021-2026 (%)
30: Geographic comparison
31: North America - Market size and forecast 2021-2026 ($ million)
32: North America - Year-over-year growth 2021-2026 (%)
33: Europe - Market size and forecast 2021-2026 ($ million)
34: Europe - Year-over-year growth 2021-2026 (%)
35: Asia - Market size and forecast 2021-2026 ($ million)
36: Asia - Year-over-year growth 2021-2026 (%)
37: ROW - Market size and forecast 2021-2026 ($ million)
38: ROW - Year-over-year growth 2021-2026 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Abbott Laboratories - Overview
48: Abbott Laboratories - Business segments
49: Abbott Laboratories - Key offerings
50: Abbott Laboratories - Key customers
51: Abbott Laboratories - Segment focus
52: Alvogen ehf - Overview
53: Alvogen ehf - Product and service
54: Alvogen ehf - Key offerings
55: Alvogen ehf - Key customers
56: Alvogen ehf - Segment focus
57: AstraZeneca Plc - Overview
58: AstraZeneca Plc - Product and service
59: AstraZeneca Plc - Key offerings
60: AstraZeneca Plc - Key customers
61: AstraZeneca Plc - Segment focus
62: Bayer AG - Overview
63: Bayer AG - Business segments
64: Bayer AG - Key offerings
65: Bayer AG - Key customers
66: Bayer AG - Segment focus
67: GlaxoSmithKline Plc - Overview
68: GlaxoSmithKline Plc - Business segments
69: GlaxoSmithKline Plc - Key offerings
70: GlaxoSmithKline Plc - Key customers
71: GlaxoSmithKline Plc - Segment focus
72: HydroCision Inc. - Overview
73: HydroCision Inc. - Product and service
74: HydroCision Inc. - Key offerings
75: HydroCision Inc. - Key customers
76: HydroCision Inc. - Segment focus
77: Merck and Co. Inc. - Overview
78: Merck and Co. Inc. - Business segments
79: Merck and Co. Inc. - Key offerings
80: Merck and Co. Inc. - Key customers
81: Merck and Co. Inc. - Segment focus
82: MiMedx Group Inc. - Overview
83: MiMedx Group Inc. - Business segments
84: MiMedx Group Inc. - Key offerings
85: MiMedx Group Inc. - Key customers
86: MiMedx Group Inc. - Segment focus
87: RAG-Stiftung - Overview
88: RAG-Stiftung - Product and service
89: RAG-Stiftung - Key offerings
90: RAG-Stiftung - Key customers
91: RAG-Stiftung - Segment focus
92: Seikagaku Corp. - Overview
93: Seikagaku Corp. - Business segments
94: Seikagaku Corp. - Key offerings
95: Seikagaku Corp. - Key customers
96: Seikagaku Corp. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Alvogen ehf
  • AstraZeneca Plc
  • Bayer AG
  • GlaxoSmithKline Plc
  • HydroCision Inc.
  • Merck and Co. Inc.
  • MiMedx Group Inc.
  • RAG-Stiftung
  • Seikagaku Corp.